H.R. 4761 would require Customs and Border Protection (CBP) to develop a strategy to ensure that opioid screening devices can detect narcotics at certain purity levels. The act also would require CBP to develop a plan to ensure the longevity of those devices.
CBP is currently carrying out activities similar to those required by H.R. 4761. Thus, CBO estimates that implementing the act would not have a significant cost; any spending would be subject to the availability of appropriated funds.
On January 15, 2020, CBO transmitted a cost estimate for H.R. 4761, the DHS Opioid Detection Resilience Act of 2019, as passed by the House of Representatives on December 9, 2019. The two versions of the legislation are similar, and CBO’s estimates of their budgetary effects are the same.
